Skip to main content
OpenTrials
Completed

NCT Number: NCT05457166

Use of the KASPARD System for Fall Prevention in Nursing Homes

Falls are a frequent cause of admission to nursing homes [2]. It is also the most frequently reported adverse event in these institutions.

The prevention of falls in EHPAD must mobilise several levers of action and involve all staff. It must be included in the establishment's project in the same way as the policy on the proper use of restraints [21].

Home automation and new technologies can contribute to the prevention of falls and their consequences. Most of the existing solutions on the market are either fall detection solutions based on a watch or pendant or rise detection solutions based on a sub-mattress or floor mat. All of these solutions work with a contact and often require a daily set-up or check by the care teams. But the real challenge today for new technologies is to prevent falls in the elderly, by directly addressing the risk factors.

KASPARD is a non-contact (remote sensors) and non-intrusive (no video image, it uses point cloud technology) solution for detecting falls, excessive wandering and nocturnal activities in a nursing home. The information is transmitted securely via the wifi network to a mobile phone (or TSI/DECT) and to a computer. The KASPARD solution, which is already on the market (non-medical CE marking), is used in several EHPADs in Belgium and France. It is not a medical device. To date, it has a sensitivity and specificity of over 90% (manufacturer's unpublished data).

We wish to verify the effectiveness of the KASPARD technology for the prevention of falls in EHPAD, suggested for the moment by an observational study, with the help of a multi-centre clinical study

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Accidental Falls Nursing Homes

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Pôle de gérontologie - Hôpital Les Bateliers

Lille, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male and/or female resident of an EHPAD
  • Person aged ≥ 65 years
  • Elderly person at high risk of falling (fell at least 1 time in the 6 months prior to inclusion)
  • Resident or his/her legal representative who has given free, written, informed consent to participate in the trial
  • Socially insured resident
  • Resident willing to comply with all study procedures and duration. The questionnaires used will be validated questionnaires for the target population (QoL-AD questionnaire for residents and their carers).

Exclusion criteria

  • Refusal to participate in the study
  • Elderly resident who has a fall and for whom the use of a restraint is deemed essential by the coordinating doctor of the EHPAD
  • Persons under legal protection are not excluded.

Treatment and study plan

KASPARD system for fall prevention in nursing homes

Device

All subjects will be monitored for 2 periods of 100 nights each. Recordings will be made continuously at night for the duration of the study Period 0: set-up, adjustment, recording (without alarm); This is a preparatory phase which is part of the usual use of the device.

Duration: 10 days Before period: The BEFORE period runs for 100 nights during which the device alarm is not activated, but the device records events.

After period: The AFTER period is 100 nights during which the device alarm is activated: Monitoring with recording + alarm activated (usual care + action if alarm is triggered)

Primary outcomes

  1. the number of falls observed over a period of 100 nights with KASPARD

    Time frame: 100 nights

    To show that the KASPARD system reduces the number of falls observed over a period of 100 nights with the device activated compared to a period of 100 nights with the device deactivated, in elderly people aged over 65 years residing in EPAD and at high risk of falling.

Secondary outcomes

  1. The number of night shift interventions

    Time frame: 100 nights with the device on versus 100 nights with the device off

  2. The number of nights without restraint

    Time frame: 100 nights with the device on versus 100 nights with the device off

  3. The time taken to intervene after a fall

    Time frame: 100 nights with the device on versus 100 nights with the device off

    Time between the occurrence of the fall and the arrival of staff at the patient's bedside

  4. Fear of falling assessed by the FES scale

    Time frame: 100 nights with the device on versus 100 nights with the device off

    Fear of falling reported by residents at the end of each period: last day of period 1 and last day of period 2

  5. Quality of life questionnaire

    Time frame: 100 nights with the device on versus 100 nights with the device off

    Quality of life questionnaire reported by the patient and once at the end of each period: last day of period 1 and last day of period 2

  6. Resident satisfaction

    Time frame: activation period of 100 nights

    Resident satisfaction will be assessed by a satisfaction questionnaire

  7. Night and day staff satisfaction

    Time frame: activation period of 100 nights

    Staff satisfaction will be assessed by a satisfaction questionnaire evaluating organisational aspects, disturbance of walking patients, interest in the reports provided by the system

Sponsors and collaborators

Lead sponsor

University Hospital, Lille

Other

Registry information

Official study title

Interest in Using the KASPARD System for the Prevention of Falls in Nursing Homes (EHPAD, for Its French Acronym)

Acronym: KASPARD

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jul 13, 2022
Registry last updated
May 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.